FDA issued a Warning Letter to Cadila Healthcare Limited on 12/23/2015 as a result of this inspection.
FDA investigators audited the Cadila Healthcare Limited (Zyfine) - Tal Sanand, Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 06 Dec 2014.
Add To Cart
- Category: Human Drugs
- Inspection end: 06 Dec 2014
- Location: Tal Sanand, Ahmedabad, India
- FEI: 3006595385